Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38323
CAS Number:
163451-81-8
Tériflunomide
Purity:
≥ 98% (CG)
Synonym(s):
N- [4-(trifluorométhyl)phényl]-2-cyano-3-hydroxycrotonamide, ( Z )-2-Cyano-3-hydroxy- N -[4-(trifluorométhyl)phényl]-2-buténamide
Documents
$189.58 /100 mg
Taille
Request Bulk Quote
Informations sur le produit

Teriflunomide is a potent immunomodulatory agent primarily utilized in the treatment of multiple sclerosis (MS). This compound functions by inhibiting the proliferation of activated lymphocytes, thereby reducing the inflammatory processes associated with MS. Its unique mechanism of action makes it a valuable option for patients seeking to manage their condition effectively. Teriflunomide is recognized for its favorable pharmacokinetic profile, allowing for once-daily oral administration, which enhances patient compliance.

In addition to its primary application in MS, Teriflunomide is being explored for potential uses in other autoimmune disorders due to its ability to modulate immune responses. Researchers appreciate its low toxicity and the absence of significant drug interactions, making it a safer alternative compared to other immunosuppressants. With ongoing studies, Teriflunomide holds promise for expanding its therapeutic applications, providing a versatile tool for healthcare professionals in managing complex autoimmune conditions.

Numéro CAS 
163451-81-8
Formule moléculaire
C12H9F3N2O2
Poids moléculaire 
270.21
Point de fusion 
227 - 231 °C
Informations générales
Numéro CAS 
163451-81-8
Formule moléculaire
C12H9F3N2O2
Poids moléculaire 
270.21
Point de fusion 
227 - 231 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Teriflunomide is widely utilized in research focused on

  • Multiple Sclerosis Treatment: This compound is primarily used as an oral medication for treating relapsing forms of multiple sclerosis (MS), helping to reduce the frequency of relapses and slow disease progression.
  • Immunomodulation: Teriflunomide works by modulating the immune system, making it beneficial for researchers studying autoimmune diseases and developing new therapies.
  • Pharmaceutical Development: Its unique mechanism of action provides a valuable model for pharmaceutical companies looking to create new immunosuppressive drugs with fewer side effects compared to traditional therapies.
  • Research in Cancer Therapy: Investigations are ongoing into its potential applications in oncology, particularly in enhancing the efficacy of certain cancer treatments through immune system modulation.
  • Comparative Effectiveness Studies: Researchers are using teriflunomide in clinical trials to compare its effectiveness and safety profile against other MS treatments, providing crucial data for healthcare providers.

Citations